Latest filing published 22 Jan 2018 for Skye Bioscience, Inc..
No signal scores available.
Cosmas N. Lykos has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Oakley Inc and Skye Bioscience, Inc. The record holds 4 filings, for trades running from 10 March 2006 to 18 January 2018.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 22 January 2018, the filings show a share grant in Skye Bioscience, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations